What is Roth Capital’s Forecast for TSE:TRU Q1 Earnings?

Trulieve Cannabis Corp. (TSE:TRU) – Research analysts at Roth Capital issued their Q1 2025 earnings estimates for shares of Trulieve Cannabis in a note issued to investors on Monday, March 3rd. Roth Capital analyst W. Kirk expects that the company will earn ($0.13) per share for the quarter. Roth Capital also issued estimates for Trulieve Cannabis’ Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.13) EPS, Q4 2025 earnings at ($0.10) EPS and FY2026 earnings at ($0.33) EPS.

Several other equities research analysts have also issued reports on TRU. Craig Hallum raised Trulieve Cannabis to a “strong-buy” rating in a research report on Wednesday, February 26th. Atb Cap Markets upgraded shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a report on Monday, December 9th. Finally, Cormark upgraded shares of Trulieve Cannabis from a “hold” rating to a “moderate buy” rating in a research note on Monday.

Trulieve Cannabis Stock Performance

Insiders Place Their Bets

In other Trulieve Cannabis news, Senior Officer Wes Getman bought 9,500 shares of the business’s stock in a transaction on Friday, December 13th. The stock was purchased at an average price of C$7.02 per share, for a total transaction of C$66,702.35.

Trulieve Cannabis Company Profile

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.